These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39297217)

  • 21. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
    Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
    Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchiectasis--diagnosis and treatment.
    Rademacher J; Welte T
    Dtsch Arztebl Int; 2011 Dec; 108(48):809-15. PubMed ID: 22211147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory infection in noncystic fibrosis bronchiectasis.
    Zoumot Z; Wilson R
    Curr Opin Infect Dis; 2010 Apr; 23(2):165-70. PubMed ID: 19996746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
    Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL
    Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
    Paredes Aller S; Quittner AL; Salathe MA; Schmid A
    Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
    Tay GT; Reid DW; Bell SC
    Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review.
    Máiz Carro L; Martínez-García MA
    Ther Adv Respir Dis; 2019; 13():1753466619866102. PubMed ID: 31390940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigational inhaled therapies for non-CF bronchiectasis.
    Antoniu SA
    Expert Opin Investig Drugs; 2018 Feb; 27(2):139-146. PubMed ID: 29338445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and tolerability of inhaled antibiotics in patients with bronchiectasis.
    Vélez-Díaz-Pallarés M; Montero-Llorente B; Parro-Martín MÁ; Martínez-Barros H; Máiz Carro L; Nieto Royo R; Gómez-Lozano A; Menacho-Román M; Álvarez-Díaz A
    Pulm Pharmacol Ther; 2022 Feb; 72():102110. PubMed ID: 35032638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational use of mucoactive medications to treat pediatric airway disease.
    Linssen RSN; Ma J; Bem RA; Rubin BK
    Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncystic Fibrosis Bronchiectasis: Evaluation of an Extensive Diagnostic Protocol in Determining Pediatric Lung Disease Etiology.
    Beckeringh NI; Rutjes NW; van Schuppen J; Kuijpers TW
    Pediatr Allergy Immunol Pulmonol; 2019 Dec; 32(4):155-162. PubMed ID: 32140286
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ; Regan KH
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD001021. PubMed ID: 29607494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expert group recommendation on inhaled mucoactive drugs in pediatric respiratory diseases: an Indian perspective.
    Singh M; Varkki S; Kinimi I; Das RR; Goyal JP; Bhat M; Dayal R; Kalyan P; Gairolla J; Khosla I
    Front Pediatr; 2023; 11():1322360. PubMed ID: 38111626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Effectiveness of hypertonic saline nebulization in airway clearance in children with noncystic fibrosis bronchiectasis: A randomized control trial.
    Valji R; Mehta R; Hicks A
    Pediatr Pulmonol; 2021 Dec; 56(12):4051-4052. PubMed ID: 34525261
    [No Abstract]   [Full Text] [Related]  

  • 40. The Impact of Cystic Fibrosis- and Noncystic Fibrosis-Bronchiectasis on Pulmonary Artery Wall Thickness and Right Heart Functions Assessed by Speckle-Tracking Echocardiography.
    Gürel E; Vezir D; Güçtekin T; Doğan Z; Kocakaya D; Olgun S; Sünbül M; Çinçin A; Özben B; Sayar N; Tigen MK; Ceyhan B
    Anatol J Cardiol; 2023 Jun; 27(6):319-327. PubMed ID: 37257004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.